Tatetsu H - Search Results

1

Maintenance and enhancement of human peripheral blood mobilized stem/progenitor cell engraftment after ex vivo culture via an HDACi/SALL4 axis (3465).

Tatetsu H, Armant M, Wang F, Gao C, Ueno S, Tian X, Federation A, Qi J, Bradner J, Tenen DG, Chai L. Tatetsu H, et al. Exp Hematol. 2019 Jul;75:53-63.e11. doi: 10.1016/j.exphem.2019.06.473. Epub 2019 Jun 28. Exp Hematol. 2019. PMID: 31260717 Free PMC article.

2

Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth.

Tatetsu H, Ueno S, Hata H, Yamada Y, Takeya M, Mitsuya H, Tenen DG, Okuno Y. Tatetsu H, et al. Cancer Res. 2007 Jun 1;67(11):5328-36. doi: 10.1158/0008-5472.CAN-06-4265. Cancer Res. 2007. PMID: 17545613

3

Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex.

Gao C, Dimitrov T, Yong KJ, Tatetsu H, Jeong HW, Luo HR, Bradner JE, Tenen DG, Chai L. Gao C, et al. Among authors: tatetsu h. Blood. 2013 Feb 21;121(8):1413-21. doi: 10.1182/blood-2012-04-424275. Epub 2013 Jan 3. Blood. 2013. PMID: 23287862 Free PMC article.

4

SALL4, the missing link between stem cells, development and cancer.

Tatetsu H, Kong NR, Chong G, Amabile G, Tenen DG, Chai L. Tatetsu H, et al. Gene. 2016 Jun 15;584(2):111-9. doi: 10.1016/j.gene.2016.02.019. Epub 2016 Feb 16. Gene. 2016. PMID: 26892498 Free PMC article. Review.

5

Leukemic survival factor SALL4 contributes to defective DNA damage repair.

Wang F, Gao C, Lu J, Tatetsu H, Williams DA, Müller LU, Cui W, Chai L. Wang F, et al. Among authors: tatetsu h. Oncogene. 2016 Nov 24;35(47):6087-6095. doi: 10.1038/onc.2016.146. Epub 2016 May 2. Oncogene. 2016. PMID: 27132514 Free PMC article.

6

Targeting SALL4 by entinostat in lung cancer.

Yong KJ, Li A, Ou WB, Hong CK, Zhao W, Wang F, Tatetsu H, Yan B, Qi L, Fletcher JA, Yang H, Soo R, Tenen DG, Chai L. Yong KJ, et al. Among authors: tatetsu h. Oncotarget. 2016 Nov 15;7(46):75425-75440. doi: 10.18632/oncotarget.12251. Oncotarget. 2016. PMID: 27705911 Free PMC article.

7

MUC1/KL-6 expression confers an aggressive phenotype upon myeloma cells.

Endo S, Nishimura N, Kawano Y, Ueno N, Ueno S, Tatetsu H, Komohara Y, Takeya M, Hata H, Mitsuya H, Masao M, Okuno Y. Endo S, et al. Among authors: tatetsu h. Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):246-252. doi: 10.1016/j.bbrc.2018.11.016. Epub 2018 Nov 10. Biochem Biophys Res Commun. 2018. PMID: 30420285

8

The Interplay between Transcription Factor SALL4 and Histone Modifiers in Hematopoietic Stem and Progenitor Cells.

Tatetsu H, Tenen DG, Chai L. Tatetsu H, et al. J Cell Immunol. 2021;3(1):26-30. doi: 10.33696/immunology.3.073. J Cell Immunol. 2021. PMID: 33884376 Free PMC article. No abstract available.

9

Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome.

Tatetsu H, Watanabe M, Liu J, Tokunaga K, Iwanaga E, Komohara Y, Thrash E, Bassal MA, Matsuoka M, Tenen DG, Chai L. Tatetsu H, et al. Clin Transl Med. 2023 Aug;13(8):e1327. doi: 10.1002/ctm2.1327. Clin Transl Med. 2023. PMID: 37501279 Free PMC article. No abstract available.

10

PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL.

Ueno S, Tatetsu H, Hata H, Iino T, Niiro H, Akashi K, Tenen DG, Mitsuya H, Okuno Y. Ueno S, et al. Among authors: tatetsu h. Oncogene. 2009 Nov 19;28(46):4116-25. doi: 10.1038/onc.2009.263. Epub 2009 Sep 14. Oncogene. 2009. PMID: 19749795 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters